Source link : https://newshealth.biz/health-news/nice-backs-first-immunotherapy-for-resectable-gastric-cancer/
NICE has recommended durvalumab for NHS use in England as part of perioperative treatment for adults with resectable gastric or gastro-oesophageal junction adenocarcinoma. Medscape News UK Source link : https://www.medscape.com/viewarticle/nice-backs-first-immunotherapy-resectable-gastric-cancer-2026a1000frm?src=rss Author : Publish date : 2026-05-15 09:49:00 Copyright for syndicated content belongs to the linked Source.
The post NICE Backs First Immunotherapy for Resectable Gastric Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-15 09:49:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8